Levo-Alphacetylmethadol en es it fr

Levo-Alphacetylmethadol Brand names, Levo-Alphacetylmethadol Analogs

Levo-Alphacetylmethadol Brand Names Mixture

  • No information avaliable

Levo-Alphacetylmethadol Chemical_Formula


Levo-Alphacetylmethadol RX_link


Levo-Alphacetylmethadol fda sheet

Levo-Alphacetylmethadol msds (material safety sheet)

Levo-Alphacetylmethadol Synthesis Reference

No information avaliable

Levo-Alphacetylmethadol Molecular Weight

353.498 g/mol

Levo-Alphacetylmethadol Melting Point

No information avaliable

Levo-Alphacetylmethadol H2O Solubility

>15 mg/mL

Levo-Alphacetylmethadol State


Levo-Alphacetylmethadol LogP


Levo-Alphacetylmethadol Dosage Forms


Levo-Alphacetylmethadol Indication

LAAM is indicated for the treatment and management of opiate dependence. It is sometimes used to treat severe pain in terminal patients.

Levo-Alphacetylmethadol Pharmacology

LAAM is a synthetic synthetic opioid analgesic with multiple actions quantitatively similar to those as morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. However, LAAM is more active and more toxic than morphine. The principal actions of therapeutic value are analgesia and sedation and detoxification or temporary maintenance in narcotic addiction. The LAAM abstinence syndrome, although qualitatively similar to that of morphine, differs in that the onset is slower, the course is more prolonged, and the symptoms are less severe.

Levo-Alphacetylmethadol Absorption

LAAM is rapidly absorbed from an oral solution.

Levo-Alphacetylmethadol side effects and Toxicity

Signs of overdose include apnea, circulatory collapse, pulmonary edema, cardiac arrest, and death.

Levo-Alphacetylmethadol Patient Information

No information avaliable

Levo-Alphacetylmethadol Organisms Affected

Humans and other mammals